Hypersensitivity Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What is Type I Hypersensitivity?

A

Immediate (anaphylactic) hypersensitivity. IgE mediated reaction to a substance that occurs minutes after contact to antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe general characteristics of Type I Hypersensitivity antigens

A

Low MW, highly soluble, stable proteins. Peptides can be expressed on MHCII and are effective at activating Th2-type cytokines (especially IL-4) and stimulate IgE response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the molecular process of initial and subsequent exposure of allergen

A

Sensitization: allergen exposed causing activation of TH2 cells and class switching to IgE in B cells. Plasma cells secrete IgE which binds to FcR(epsilon) on mast cells, basophils, and eosinophils. Subsequent Exposure: Bound IgE-FCR(ep) crosslinks with antigen causing mast cell degranulation. Immediate hypersens. and Late phase rxns occur.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the effects of mast cell degranulation in a Type I Hypersensitivity rxn?

A

Vascular leak (histamine), bronchoconstriction, intestinal hypermotility, inflamm, tissue remodeling (enzymes [tryptase])

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the terms used to describe the early and late phases of a Type I Hyper. Rxn?

A

Wheal and Flare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What causes hypermotility in a Type I Hyper. Rxn?

A

Eosinophils - their original purpose is to increase motility and mucous production to expel parasites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the response of subcutaneous allergen Type I Hyper. Rxn.

A

Antigen activates mast cells which causes an increase in vascular permeability and localized swelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the response to inhaled allergens in Type I Hyper. Rxn.

A

Exposure: Inhaled allergen ingested by APC which activates T cells. Causes T cell secretion of IL-4 and IgE class switching. Subsequent exposure: Antigen activates mast cells which increase vascular permeability and activation of epithelium. Eosinophils enter nasal passages.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the allergic asthma response

A

(Acute) Mucosal mast cells capture antigen which expel inflammatory mediators that contract smooth muscle, increase mucus secretion, and increase vascular permeability. (Chronic) TH2 cells produce IL-13 without allergen stimulation. Eosinophils also mediate. Chronic inflamm results in tissue remodeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe reaction to food allergies

A

Sensitized mast cells release histamine which acts on epithelium, blood vessels, and smooth muscle resulting in urticaria, muscle contractions, vomiting, diarrhea, fluid outflow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the response to systemic allergens

A

Most severe Type I rxn. Increased capillary permeability, swelling of tissues, loss of blood pressure, hypoxia, irregular heartbeat, anaphylactic shock, smooth muscle contraction of lungs, contraction of GI smooth muscle, N/V/D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Two hypotheses accounting for increased hypersensitivity

A

Hygiene hypothesis: poor hygeine -> exposure to TH1 infections which protect against allergy. Counter Regulation Hypothesis: Infections that lead to IL-10 and TGF(Beta) production downregulate both TH1 and 2 so less hypersensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tx of allergies

A

Avoid allergen, drugs (antihistamines, corticosteroids, montelukast), Desensitization via controlled exposure with allergy shots (increase IgG and A to block IgE), Allenergic peptide caccination to anergize allergen specific T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe type II Hypersensitivity Rxns. Examples?

A

Ab-mediated Cytotoxic Hypersensitivity. Mediated by IgG. Abs bind to antigen and cause lysis via complement or complement induced phagocytosis of cell-antigen-Ab complex. Mismatched blood transfusions or drug-modified surface antigens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe type III Hypersensitvity Rxns.

A

Immune complex-mediated hypersensitivity. Large quantities of soluble antigen and their Abs form large latticed immune complexes that can deposit systemically in any of a variety of tissue sites causing occlusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Examples of type III Hyper. Rxn?

A

Arthus rxn: localized injection of antigen binds IgG, activates complement and results in localized inflamm; Serum scikness; Post-strep glomerulonephritis

17
Q

Describe type IV Hypersensitivity Rxns

A

Delayed (cell-mediated) hypersensitivity - Antigen-specific TH1 cells which initiate inflammatory rxns via production of cytokines. Rxn requires 100-1000X more antigen compared to B-cell mediated rxns

18
Q

What are 3 types of type IV Hyper. Rxns?

A

Delayed-type Hypersensitivity - Injected antigen processed by APCs. TH1 cells recognize antigen and recruit Tcells, phagocytes, fluid and protein to site (Basis of PPD); Contact hypersensitivity: T cells are sensitized and then react to antigen (including pentadecacatechol, nickel, latex). CD8 Tcells cause dermatitis; Celiac disease: caused by gliadin

19
Q

Which cell is central to Type IV Hypersensitivity? How?

A

TH1 cell recruits macrophages (chemokines), macrophage activation (IFN(gamma), tissue destruction (TNF(alpha) and Lymphtoxin), monocyte production by BM stem cells (IL-3, GM-CSF)

20
Q

How to treat Type II, III, and IV hypersensitivity RXN

A

Avoid antigen, reduce antigen impact with NSAIDs and steroids, reduction of immune response by targeting pathogenic T and B cells, induce T cell regulatory response (peptide vaccination), block cytokines